Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases

dc.contributor.authorid0000-0002-2730-7307
dc.contributor.authorid0000-0002-1171-6819
dc.contributor.authoridN/A
dc.contributor.authorid0000-0001-5603-0004
dc.contributor.authorid0000-0001-6582-7031
dc.contributor.authorid0000-0002-0933-6198
dc.contributor.authorid0000-0003-4618-0273
dc.contributor.authorid0000-0002-6141-9038
dc.contributor.coauthorTezelman, Serdar
dc.contributor.coauthorTerzioglu, Tarik
dc.contributor.coauthorColakoglu, Bulen Demirkol, Mehmet Onur
dc.contributor.coauthorKapran, Yersu
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.kuauthorSezer, Havva
dc.contributor.kuauthorCanbaz, Hande Bulut
dc.contributor.kuauthorÇilingiroğlu Eda Nur
dc.contributor.kuauthorDereli, Dilek Yazıcı
dc.contributor.kuauthorDeyneli, Oğuzhan
dc.contributor.kuauthorBatman, Adnan
dc.contributor.kuauthorÖzışık, Seçil
dc.contributor.kuauthorAlagöl, Faruk
dc.contributor.kuprofileTeaching Faculty
dc.contributor.kuprofileMaster Student
dc.contributor.kuprofileNurse
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteGraduate School of Health Sciences
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.unitKoç University Hospital
dc.contributor.yokid154807
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid179659
dc.contributor.yokid171914
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.date.accessioned2025-01-19T10:32:02Z
dc.date.issued2023
dc.description.abstractIntroduction: Our aims were to explore the relationship between primary hyperparathyroidism (pHPT) and malignant tumour develop- ment, to determine the frequency and the time of occurrence of malignant tumours in patients with pHPT, and to evaluate the charac- teristics of pHPT in these patients. Material and methods: This retrospective cohort study included consecutive individuals who were diagnosed with pHPT aged 18 years or older in a university hospital during a 7-year period. A total of 198 patients with pHPT were reviewed retrospectively. Demographic, clinical, biochemical, radiologic findings, and histopathological diagnosis were collected from the electronic medical records of the hospital system. Results: The mean age of the study population was 58 13 years and was predominantly female (female/male: 162/36). There were 42 (21.2%) patients with malignant tumours. Five (12%) out of 42 patients had metachronous double malignancies. The most common 2 concurrent malignancies were breast (36.1%) and thyroid (17.0%). Sixty-eight per cent of the malignant tumours occurred before the di- agnosis of pHPT. A higher percentage (87.5%) of simultaneous tumours was seen in the thyroid gland. No statistically significant differ- ences were observed between patients with and without malignant tumours in terms of demographic, clinical, biochemical, radiological, and histopathological features. The median follow-up duration was 24 months after parathyroid surgery. Conclusion: The results of this study revealed that pHPT was associated with various tumour types. The frequency of malignant tumours was 21.2%. Breast and thyroid cancers were the most common 2 cancers coexisting with pHPT. A large percentage of malignant tumours occurred before the diagnosis of pHPT. A higher percentage of simultaneous tumours was seen in the thyroid gland. pHPT patients with and without malignant tumours seemed to have similar characteristics.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue4
dc.description.openaccessgold
dc.description.publisherscopeInternational
dc.description.volume74
dc.identifier.doi10.5603/EP.a2023.0055
dc.identifier.issn0423-104X
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85176587976
dc.identifier.urihttps://doi.org/10.5603/EP.a2023.0055
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26349
dc.identifier.wos1118653900001
dc.keywordsMalignant tumour
dc.keywordsHypercalcaemia
dc.keywordsPrimary hyperparathyroidism
dc.keywordsEndocrinology
dc.keywordsMetabolism
dc.languageen
dc.publisherVia Medica
dc.sourceEndokrynologia Polska
dc.subjectMedicine
dc.titlePrevious, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases
dc.typeJournal Article

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
IR05468.pdf
Size:
318.8 KB
Format:
Adobe Portable Document Format